Cue Biopharma Inc

Company Snapshot
40 Guest Street
Boston, MA 02135
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 53
https://www.cuebiopharma.com
Please select from the dropdown
  1. Executive Compensation
  2. > Cue Biopharma Inc
Company Financials

2021
2022
2023
Gross Profit
Operating Income
-$43,712,073
-$53,501,442
-$51,992,000
Net Income
-$44,161,175
-$53,010,382
-$50,733,000
2021
Gross Profit
Operating Income
-$43,712,073
Net Income
-$44,161,175
2022
Gross Profit
Operating Income
-$53,501,442
Net Income
-$53,010,382
2023
Gross Profit
Operating Income
-$51,992,000
Net Income
-$50,733,000
The above data on Cue Biopharma Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Daniel Passeri
Chief Executive Officer and Director
$604,824
$2,407,500
$3,156
$3,015,480
Daniel Passeri
$3,015,480
Chief Executive Officer and Director
Anish Suri
President and Chief Scientific Officer
$481,486
$757,826
$3,156
$1,242,468
Anish Suri
$1,242,468
President and Chief Scientific Officer
Kerri-Ann Millar
Chief Financial Officer and Principal Accounting Officer
$444,181
$715,201
$3,156
$1,162,538
Kerri-Ann Millar
$1,162,538
Chief Financial Officer and Principal Accounting Officer
Pamela Garzone
Director
$30,139
$111,692
$0
$141,831
Pamela Garzone
$141,831
Director
Patrick Verheyen
Director
$35,146
$100,168
$0
$135,314
Patrick Verheyen
$135,314
Director
Cue Biopharma Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us